Removing Screen Time for One Hour Before Bed Aids Toddlers' Sleep
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 22, 2024 -- Parents can feasibly remove toddler screen time in the hour before bed and this removal is associated with improvements in toddler sleep, according to a study published online Oct. 21 in JAMA Pediatrics.
Hannah Pickard, Ph.D., from University of London, and colleagues tested the feasibility of a seven-week, parent-administered screen time intervention (PASTI) in toddlers (aged 16 to 30 months) who have screen time in the hour before bed and assessed the impact of PASTI on toddlers' sleep and attention. The analysis included 105 families randomly assigned to the PASTI of removing screen time in the hour before bed plus use of a bedtime box (BB) of reading and puzzles, a BB only, or no intervention.
The researchers found that 94 percent of families adhered to PASTI, and PASTI was associated with reductions in parent-reported screen time. There were also small-to-medium improvements seen in objectively measured sleep efficiency with PASTI, as well as in night awakenings, and reduced daytime sleep. There was no association between PASTI and objective measures of attention. Compared with BB only, PASTI was associated with a difference in parent-reported effortful control and inhibitory control due to an increase in BB-only scores.
"Our findings support current pediatric guidance to avoid screen time in the hour before toddler bedtime," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-23 06:00
Read more
- No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
- Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
- Overtreatment Common for Older Men With Prostate Cancer
- JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
- UroGen Announces FDA Acceptance of its New Drug Application for UGN-102
- First Cases of Sexually Transmitted Ringworm Reported in the U.S.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions